(MENAFN- PR Newswire) New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day BANGALORE, India, March 14, 2024 ...
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), reports that that its newly upgraded biologics facility (Unit 3) in Bangalore, India, will be ...
BENGALURU (Reuters) -India's Syngene International Ltd aims to supply half-a-million vials of COVID-19 drug remdesivir through its local distribution partners next month, its top executive said, as ...
Syngene International, a global contract research, development and manufacturing organization (CRDMO), has said that its newly upgraded biologics facility: Unit 3 would be operational for clinical and ...
BENGALURU (Reuters) - India's Syngene International Ltd aims to supply half-a-million vials of COVID-19 drug remdesivir through its local distribution partners next month, its top executive said, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results